A woman with ferritin 300 ng/mL and vitamin B12 172 pg/mL has intermittent diffuse hair shedding for two years; what is the likely cause and how should it be managed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 23, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Intermittent Diffuse Hair Shedding: Vitamin B12 Deficiency is the Primary Culprit

The most likely cause of this woman's two-year intermittent diffuse hair shedding is vitamin B12 deficiency (172 pg/mL), not iron deficiency, as her ferritin of 300 ng/mL is elevated and suggests adequate to excess iron stores. 1, 2

Understanding the Laboratory Values

Ferritin 300 ng/mL - Not Iron Deficient

  • Ferritin of 300 ng/mL is well above the threshold for iron deficiency and actually suggests adequate iron stores or possible inflammation 1, 2
  • Without inflammation, ferritin <30 μg/L defines iron deficiency; with inflammation present, the lower limit increases to 100 μg/L 2
  • For hair loss specifically, ferritin ≤15 μg/L confirms iron deficiency with 98% specificity in premenopausal women 2, 3
  • This patient's ferritin is 20-fold higher than the deficiency threshold, making iron deficiency an unlikely cause 4

Critical caveat: Ferritin is an acute-phase reactant and can be falsely elevated during infection, inflammation, chronic disease, malignancy, or liver damage 2. Check CRP and/or ESR to rule out inflammation masking true iron deficiency 2.

Vitamin B12 172 pg/mL - Deficient

  • Vitamin B12 deficiency is defined as levels <200 pg/mL 5
  • This patient's B12 of 172 pg/mL falls below this threshold and represents true deficiency 5
  • Vitamin B12 deficiency that progresses for longer than 3 months may produce permanent degenerative lesions of the spinal cord 6

Recommended Diagnostic Workup

Before initiating treatment, complete the following:

  • CBC to assess for anemia (Hb <12 g/dL in women) 3
  • TSH to rule out thyroid dysfunction as a contributing factor 3
  • Transferrin saturation (from serum iron and total iron-binding capacity) - less affected by inflammation than ferritin 2
  • CRP and/or ESR to detect inflammation that could distort ferritin interpretation 2
  • Tissue transglutaminase (TTG) antibodies if unexplained deficiency is found, to rule out celiac disease 3

Treatment Approach

Vitamin B12 Replacement - Primary Intervention

Initiate vitamin B12 supplementation immediately given the confirmed deficiency and risk of irreversible neurologic damage 6:

  • If pernicious anemia is diagnosed, monthly intramuscular injections of vitamin B12 for life are required 6
  • Failure to treat will result in return of anemia and development of incapacitating and irreversible damage to the nerves of the spinal cord 6
  • Monitor serum potassium closely during the first 48 hours of treatment and replace if necessary 6
  • Obtain hematocrit and reticulocyte counts daily from days 5-7 of therapy, then frequently until hematocrit normalizes 6

Iron Supplementation - Not Indicated

  • Do not supplement iron with ferritin of 300 ng/mL unless transferrin saturation is low (<16%) or inflammation is confirmed 2
  • If inflammation is present and transferrin saturation is low, consider iron supplementation with a target ferritin ≥60 μg/L 2

Folic Acid Consideration

  • Never give folic acid without vitamin B12 in this patient 6
  • Doses of folic acid >0.1 mg/day may produce hematologic remission in B12 deficiency but will not prevent neurologic manifestations 6
  • Folic acid may mask B12 deficiency while allowing progression of irreversible spinal cord damage 6
  • If folate levels are also low, administer folic acid together with vitamin B12 6, 7

Prognosis and Follow-up

  • Hair loss due to nutritional deficiency develops gradually over months 3
  • Iron supplementation started within 6 months of onset results in better prognosis for iron-related hair loss, but this patient likely has B12-related hair loss 2, 3
  • Monitor vitamin B12, folate, iron levels, hematocrit, and reticulocyte counts as outlined above 6
  • Re-evaluate if reticulocytes do not increase or if they fail to remain at least twice normal while hematocrit is <35% 6

Common Pitfall to Avoid

The most dangerous error would be treating with folic acid alone or assuming the elevated ferritin indicates iron overload requiring no intervention. Always check inflammatory markers before dismissing iron deficiency based solely on ferritin, and always supplement B12 before or concurrent with folic acid 2, 6.

References

Guideline

Iron Deficiency and Hair Loss

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Iron Deficiency and Hair Loss

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Determining Female Pattern Hair Loss vs. Nutritional Deficiency/Anemia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What is the diagnosis and management plan for a patient with anemia given normal vitamin B12 levels, slightly low ferritin levels, and other biochemical investigation results?
Does a 71‑year‑old woman with hemoglobin 10.7 g/dL, mean corpuscular volume 92 fL, red cell distribution width 15.8%, neutrophil count 8,052/µL, serum iron 39 µg/dL, transferrin saturation 98%, ferritin 913 ng/mL, vitamin B12 312 pg/mL, and folate 9.2 ng/mL require iron supplementation?
What is the ideal ferritin level for a 15-year-old female with a current ferritin level of 10 ng/mL?
What is the cause of anemia in an Amish child repeatedly consuming goat milk?
What is the appropriate management for a patient with severe anemia, macrocytosis, high serum iron, high serum ferritin, and high transferrin saturation, with normal vitamin B12 and folic acid levels?
How should clindamycin be given (route, dose, frequency, and duration) in adults and children, and what dosing adjustments are required for hepatic impairment or contraindications such as prior C. difficile colitis or lincosamide hypersensitivity?
In adult patients with rheumatoid arthritis, what is the recommended role, dosing, duration, and monitoring of glucocorticoids (e.g., prednisone) as adjunct therapy, including contraindications and use of intra‑articular injections?
Is off‑label methylene blue appropriate for cognitive (brain) enhancement, and what dosing regimen and safety precautions (including G6PD deficiency, serotonergic drug interactions, pregnancy, anemia, and renal or hepatic impairment) should be considered?
What is the recommended treatment approach for a 57‑year‑old woman with myeloperoxidase anti‑neutrophil cytoplasmic antibody‑positive systemic vasculitis?
How should methotrexate be administered with folic acid in an adult with rheumatoid arthritis?
What is the appropriate diagnostic workup for a patient suspected of myeloperoxidase (MPO) anti‑neutrophil cytoplasmic antibody (ANCA)‑associated systemic vasculitis?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.